Matthew J Peerce
Examiner (ID: 3603, Phone: (571)272-6570 , Office: P/2875 )
Most Active Art Unit | 2875 |
Art Unit(s) | 2875 |
Total Applications | 592 |
Issued Applications | 390 |
Pending Applications | 57 |
Abandoned Applications | 144 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8486131
[patent_doc_number] => 20120285538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'DYE COMPOUND, DYE-SENSITIZED SOLAR CELL USING THE SAME AND DYE SOLUTION'
[patent_app_type] => utility
[patent_app_number] => 13/180681
[patent_app_country] => US
[patent_app_date] => 2011-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5426
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13180681
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/180681 | DYE COMPOUND, DYE-SENSITIZED SOLAR CELL USING THE SAME AND DYE SOLUTION | Jul 11, 2011 | Abandoned |
Array
(
[id] => 7712333
[patent_doc_number] => 20120004415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'Chiral Synthesis of Pyrrolidine Core Compounds en route to Neuronal Nitric Oxide Synthase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/174982
[patent_app_country] => US
[patent_app_date] => 2011-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7809
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13174982
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/174982 | Chiral synthesis of pyrrolidine core compounds en route to neuronal nitric oxide synthase inhibitors | Jun 30, 2011 | Issued |
Array
(
[id] => 7733931
[patent_doc_number] => 20120016130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'PROCESS FOR PREPARING A BIPHENYL-2-YLCARBAMIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/173274
[patent_app_country] => US
[patent_app_date] => 2011-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7628
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20120016130.pdf
[firstpage_image] =>[orig_patent_app_number] => 13173274
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/173274 | Process for preparing a biphenyl-2-ylcarbamic acid | Jun 29, 2011 | Issued |
Array
(
[id] => 9413694
[patent_doc_number] => 08697731
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-15
[patent_title] => 'Derivatives of 2-pyridin-2-yl-pyrazol-3(2H)-one, preparation and therapeutic use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/172321
[patent_app_country] => US
[patent_app_date] => 2011-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17757
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13172321
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/172321 | Derivatives of 2-pyridin-2-yl-pyrazol-3(2H)-one, preparation and therapeutic use thereof | Jun 28, 2011 | Issued |
Array
(
[id] => 8904844
[patent_doc_number] => 20130172347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'C5AR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/806339
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 24689
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806339
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/806339 | C5AR antagonists | Jun 23, 2011 | Issued |
Array
(
[id] => 8063633
[patent_doc_number] => 20110245226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/155460
[patent_app_country] => US
[patent_app_date] => 2011-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92882
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245226.pdf
[firstpage_image] =>[orig_patent_app_number] => 13155460
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/155460 | PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Jun 7, 2011 | Abandoned |
Array
(
[id] => 9958061
[patent_doc_number] => 09006268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => 'Prolylcarboxypeptidase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/702656
[patent_app_country] => US
[patent_app_date] => 2011-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23869
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702656
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/702656 | Prolylcarboxypeptidase inhibitors | Jun 5, 2011 | Issued |
Array
(
[id] => 6017229
[patent_doc_number] => 20110224440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'PROCESSES FOR THE PREPARATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/117196
[patent_app_country] => US
[patent_app_date] => 2011-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12394
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224440.pdf
[firstpage_image] =>[orig_patent_app_number] => 13117196
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/117196 | Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds | May 26, 2011 | Issued |
Array
(
[id] => 7568064
[patent_doc_number] => 20110288127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE'
[patent_app_type] => utility
[patent_app_number] => 13/117066
[patent_app_country] => US
[patent_app_date] => 2011-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 11774
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288127.pdf
[firstpage_image] =>[orig_patent_app_number] => 13117066
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/117066 | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione | May 25, 2011 | Issued |
Array
(
[id] => 8302189
[patent_doc_number] => 20120184748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'RECYCLABLE CATALYSTS FOR ESTERIFICATION OR ACYLATION OF ALCOHOLS'
[patent_app_type] => utility
[patent_app_number] => 13/115245
[patent_app_country] => US
[patent_app_date] => 2011-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3192
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13115245
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/115245 | RECYCLABLE CATALYSTS FOR ESTERIFICATION OR ACYLATION OF ALCOHOLS | May 24, 2011 | Abandoned |
Array
(
[id] => 10649319
[patent_doc_number] => 09365553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-14
[patent_title] => 'Heterocyclic compound and H1 receptor antagonist'
[patent_app_type] => utility
[patent_app_number] => 13/699892
[patent_app_country] => US
[patent_app_date] => 2011-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 49820
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699892
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/699892 | Heterocyclic compound and H1 receptor antagonist | May 22, 2011 | Issued |
Array
(
[id] => 8846330
[patent_doc_number] => 08455512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-04
[patent_title] => 'Therapeutic pyrazolyl thienopyridines'
[patent_app_type] => utility
[patent_app_number] => 13/112520
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25950
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112520
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/112520 | Therapeutic pyrazolyl thienopyridines | May 19, 2011 | Issued |
Array
(
[id] => 7491110
[patent_doc_number] => 20110237802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'LENALIDOMIDE SOLVATES AND PROCESSES'
[patent_app_type] => utility
[patent_app_number] => 13/109232
[patent_app_country] => US
[patent_app_date] => 2011-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7201
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237802.pdf
[firstpage_image] =>[orig_patent_app_number] => 13109232
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/109232 | LENALIDOMIDE SOLVATES AND PROCESSES | May 16, 2011 | Abandoned |
Array
(
[id] => 8538408
[patent_doc_number] => 08314129
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-20
[patent_title] => 'Optical isomers of an iloperidone metabolite'
[patent_app_type] => utility
[patent_app_number] => 13/096015
[patent_app_country] => US
[patent_app_date] => 2011-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1739
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13096015
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/096015 | Optical isomers of an iloperidone metabolite | Apr 27, 2011 | Issued |
Array
(
[id] => 7509793
[patent_doc_number] => 20110256064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins'
[patent_app_type] => utility
[patent_app_number] => 13/087846
[patent_app_country] => US
[patent_app_date] => 2011-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21246
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256064.pdf
[firstpage_image] =>[orig_patent_app_number] => 13087846
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/087846 | Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins | Apr 14, 2011 | Abandoned |
Array
(
[id] => 7561839
[patent_doc_number] => 20110275672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'METHODS FOR TREATING CANCERS USING POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE'
[patent_app_type] => utility
[patent_app_number] => 13/073897
[patent_app_country] => US
[patent_app_date] => 2011-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 24826
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275672.pdf
[firstpage_image] =>[orig_patent_app_number] => 13073897
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/073897 | METHODS FOR TREATING CANCERS USING POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE | Mar 27, 2011 | Abandoned |
Array
(
[id] => 7561806
[patent_doc_number] => 20110275639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'C5aR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/072616
[patent_app_country] => US
[patent_app_date] => 2011-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 24723
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275639.pdf
[firstpage_image] =>[orig_patent_app_number] => 13072616
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/072616 | C5aR ANTAGONISTS | Mar 24, 2011 | Abandoned |
Array
(
[id] => 7696095
[patent_doc_number] => 20110230495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => '1-(2-PHENOXYMETHYLHETEROARYL)PIPERIDINE AND PIPERAZINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/052273
[patent_app_country] => US
[patent_app_date] => 2011-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32153
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230495.pdf
[firstpage_image] =>[orig_patent_app_number] => 13052273
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/052273 | 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds | Mar 20, 2011 | Issued |
Array
(
[id] => 8417857
[patent_doc_number] => 20120245357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'ALR2 INHIBITORS AND THEIR SYNTHESIS FROM A NATURAL SOURCE'
[patent_app_type] => utility
[patent_app_number] => 13/376661
[patent_app_country] => US
[patent_app_date] => 2011-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13809
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376661
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/376661 | ALR2 INHIBITORS AND THEIR SYNTHESIS FROM A NATURAL SOURCE | Mar 20, 2011 | Abandoned |
Array
(
[id] => 7712180
[patent_doc_number] => 20120004315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'Selective Estrogen Receptor Modulator'
[patent_app_type] => utility
[patent_app_number] => 13/048391
[patent_app_country] => US
[patent_app_date] => 2011-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 189820
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13048391
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/048391 | Selective estrogen receptor modulator | Mar 14, 2011 | Issued |